世界の非黒色腫皮膚がんの治療市場：市場規模・現状・予測

• 英文タイトル：Global Non-Melanoma Skin Cancer Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7688
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、101ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、非黒色腫皮膚がんの治療のグローバル市場について調査・分析したレポートで、種類別（化学療法、放射線療法、光線力学療法）、用途別（病院、診療所、外来手術センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・非黒色腫皮膚がんの治療の世界市場規模
・主要企業別市場シェア
・非黒色腫皮膚がんの治療の世界市場規模：種類別（化学療法、放射線療法、光線力学療法）
・非黒色腫皮膚がんの治療の世界市場規模：用途別（病院、診療所、外来手術センター、その他）
・非黒色腫皮膚がんの治療のアメリカ市場規模（種類別、用途別）
・非黒色腫皮膚がんの治療のヨーロッパ市場規模（種類別、用途別）
・非黒色腫皮膚がんの治療の中国市場規模（種類別、用途別）
・非黒色腫皮膚がんの治療の日本市場規模（種類別、用途別）
・非黒色腫皮膚がんの治療の東南アジア市場規模（種類別、用途別）
・非黒色腫皮膚がんの治療のインド市場規模（種類別、用途別）
・非黒色腫皮膚がんの治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・非黒色腫皮膚がんの治療の世界市場予測（2019年-2025年）
・非黒色腫皮膚がんの治療の地域別市場予測（2019年-2025年）
...

Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts.Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlikely to cede this commanding position anytime soon.
In 2018, the global Non-Melanoma Skin Cancer Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Non-Melanoma Skin Cancer Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-Melanoma Skin Cancer Treatment development in United States, Europe and China.

The key players covered in this study
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Roche
Merck
Novartis
Mylan
Sun Pharmaceutical
Almirall
Elekta
Varian Medical Systems
Sensus Healthcare
iCAD
Accuray
Ion Beam Applications

Market segment by Type, the product can be split into
Chemotherapy
Radiation Therapy
Photodynamic Therapy

Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Non-Melanoma Skin Cancer Treatment status, future forecast, growth opportunity, key market and key players.
To present the Non-Melanoma Skin Cancer Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Non-Melanoma Skin Cancer Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Non-Melanoma Skin Cancer Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Radiation Therapy
1.4.4 Photodynamic Therapy
1.5 Market by Application
1.5.1 Global Non-Melanoma Skin Cancer Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Non-Melanoma Skin Cancer Treatment Market Size
2.2 Non-Melanoma Skin Cancer Treatment Growth Trends by Regions
2.2.1 Non-Melanoma Skin Cancer Treatment Market Size by Regions (2014-2025)
2.2.2 Non-Melanoma Skin Cancer Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Non-Melanoma Skin Cancer Treatment Market Size by Manufacturers
3.1.1 Global Non-Melanoma Skin Cancer Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Non-Melanoma Skin Cancer Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Non-Melanoma Skin Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Non-Melanoma Skin Cancer Treatment Key Players Head office and Area Served
3.3 Key Players Non-Melanoma Skin Cancer Treatment Product/Solution/Service
3.4 Date of Enter into Non-Melanoma Skin Cancer Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Non-Melanoma Skin Cancer Treatment Market Size by Type (2014-2019)
4.2 Global Non-Melanoma Skin Cancer Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Non-Melanoma Skin Cancer Treatment Market Size (2014-2019)
5.2 Non-Melanoma Skin Cancer Treatment Key Players in United States
5.3 United States Non-Melanoma Skin Cancer Treatment Market Size by Type
5.4 United States Non-Melanoma Skin Cancer Treatment Market Size by Application

6 Europe
6.1 Europe Non-Melanoma Skin Cancer Treatment Market Size (2014-2019)
6.2 Non-Melanoma Skin Cancer Treatment Key Players in Europe
6.3 Europe Non-Melanoma Skin Cancer Treatment Market Size by Type
6.4 Europe Non-Melanoma Skin Cancer Treatment Market Size by Application

7 China
7.1 China Non-Melanoma Skin Cancer Treatment Market Size (2014-2019)
7.2 Non-Melanoma Skin Cancer Treatment Key Players in China
7.3 China Non-Melanoma Skin Cancer Treatment Market Size by Type
7.4 China Non-Melanoma Skin Cancer Treatment Market Size by Application

8 Japan
8.1 Japan Non-Melanoma Skin Cancer Treatment Market Size (2014-2019)
8.2 Non-Melanoma Skin Cancer Treatment Key Players in Japan
8.3 Japan Non-Melanoma Skin Cancer Treatment Market Size by Type
8.4 Japan Non-Melanoma Skin Cancer Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Non-Melanoma Skin Cancer Treatment Market Size (2014-2019)
9.2 Non-Melanoma Skin Cancer Treatment Key Players in Southeast Asia
9.3 Southeast Asia Non-Melanoma Skin Cancer Treatment Market Size by Type
9.4 Southeast Asia Non-Melanoma Skin Cancer Treatment Market Size by Application

10 India
10.1 India Non-Melanoma Skin Cancer Treatment Market Size (2014-2019)
10.2 Non-Melanoma Skin Cancer Treatment Key Players in India
10.3 India Non-Melanoma Skin Cancer Treatment Market Size by Type
10.4 India Non-Melanoma Skin Cancer Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Non-Melanoma Skin Cancer Treatment Market Size (2014-2019)
11.2 Non-Melanoma Skin Cancer Treatment Key Players in Central & South America
11.3 Central & South America Non-Melanoma Skin Cancer Treatment Market Size by Type
11.4 Central & South America Non-Melanoma Skin Cancer Treatment Market Size by Application

12 International Players Profiles
12.1 Boehringer Ingelheim
12.1.1 Boehringer Ingelheim Company Details
12.1.2 Company Description and Business Overview
12.1.3 Non-Melanoma Skin Cancer Treatment Introduction
12.1.4 Boehringer Ingelheim Revenue in Non-Melanoma Skin Cancer Treatment Business (2014-2019)
12.1.5 Boehringer Ingelheim Recent Development
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Company Details
12.2.2 Company Description and Business Overview
12.2.3 Non-Melanoma Skin Cancer Treatment Introduction
12.2.4 Bristol-Myers Squibb Revenue in Non-Melanoma Skin Cancer Treatment Business (2014-2019)
12.2.5 Bristol-Myers Squibb Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Company Details
12.3.2 Company Description and Business Overview
12.3.3 Non-Melanoma Skin Cancer Treatment Introduction
12.3.4 Eli Lilly Revenue in Non-Melanoma Skin Cancer Treatment Business (2014-2019)
12.3.5 Eli Lilly Recent Development
12.4 Roche
12.4.1 Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Non-Melanoma Skin Cancer Treatment Introduction
12.4.4 Roche Revenue in Non-Melanoma Skin Cancer Treatment Business (2014-2019)
12.4.5 Roche Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Non-Melanoma Skin Cancer Treatment Introduction
12.5.4 Merck Revenue in Non-Melanoma Skin Cancer Treatment Business (2014-2019)
12.5.5 Merck Recent Development
12.6 Novartis
12.6.1 Novartis Company Details
12.6.2 Company Description and Business Overview
12.6.3 Non-Melanoma Skin Cancer Treatment Introduction
12.6.4 Novartis Revenue in Non-Melanoma Skin Cancer Treatment Business (2014-2019)
12.6.5 Novartis Recent Development
12.7 Mylan
12.7.1 Mylan Company Details
12.7.2 Company Description and Business Overview
12.7.3 Non-Melanoma Skin Cancer Treatment Introduction
12.7.4 Mylan Revenue in Non-Melanoma Skin Cancer Treatment Business (2014-2019)
12.7.5 Mylan Recent Development
12.8 Sun Pharmaceutical
12.8.1 Sun Pharmaceutical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Non-Melanoma Skin Cancer Treatment Introduction
12.8.4 Sun Pharmaceutical Revenue in Non-Melanoma Skin Cancer Treatment Business (2014-2019)
12.8.5 Sun Pharmaceutical Recent Development
12.9 Almirall
12.9.1 Almirall Company Details
12.9.2 Company Description and Business Overview
12.9.3 Non-Melanoma Skin Cancer Treatment Introduction
12.9.4 Almirall Revenue in Non-Melanoma Skin Cancer Treatment Business (2014-2019)
12.9.5 Almirall Recent Development
12.10 Elekta
12.10.1 Elekta Company Details
12.10.2 Company Description and Business Overview
12.10.3 Non-Melanoma Skin Cancer Treatment Introduction
12.10.4 Elekta Revenue in Non-Melanoma Skin Cancer Treatment Business (2014-2019)
12.10.5 Elekta Recent Development
12.11 Varian Medical Systems
12.12 Sensus Healthcare
12.13 iCAD
12.14 Accuray
12.15 Ion Beam Applications

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Non-Melanoma Skin Cancer Treatment Key Market Segments
Table Key Players Non-Melanoma Skin Cancer Treatment Covered
Table Global Non-Melanoma Skin Cancer Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Non-Melanoma Skin Cancer Treatment Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Photodynamic Therapy Figures
Table Key Players of Photodynamic Therapy
Table Global Non-Melanoma Skin Cancer Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Others Case Studies
Figure Non-Melanoma Skin Cancer Treatment Report Years Considered
Table Global Non-Melanoma Skin Cancer Treatment Market Size 2014-2025 (Million US$)
Figure Global Non-Melanoma Skin Cancer Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Non-Melanoma Skin Cancer Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Non-Melanoma Skin Cancer Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Non-Melanoma Skin Cancer Treatment Market Share by Regions 2014-2019
Figure Global Non-Melanoma Skin Cancer Treatment Market Share by Regions 2014-2019
Figure Global Non-Melanoma Skin Cancer Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Non-Melanoma Skin Cancer Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Non-Melanoma Skin Cancer Treatment Market Share by Manufacturers (2014-2019)
Figure Global Non-Melanoma Skin Cancer Treatment Market Share by Manufacturers in 2018
Table Global Non-Melanoma Skin Cancer Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Non-Melanoma Skin Cancer Treatment Product/Solution/Service
Table Date of Enter into Non-Melanoma Skin Cancer Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Non-Melanoma Skin Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Non-Melanoma Skin Cancer Treatment Market Size Share by Type (2014-2019)
Figure Global Non-Melanoma Skin Cancer Treatment Market Size Market Share by Type (2014-2019)
Table Global Non-Melanoma Skin Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Non-Melanoma Skin Cancer Treatment Market Size Share by Application (2014-2019)
Figure Global Non-Melanoma Skin Cancer Treatment Market Size Market Share by Application (2014-2019)
Figure Global Non-Melanoma Skin Cancer Treatment Revenue Market Share by Application in 2018
Figure United States Non-Melanoma Skin Cancer Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Non-Melanoma Skin Cancer Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Non-Melanoma Skin Cancer Treatment Market Share (2018-2019)
Table United States Non-Melanoma Skin Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Non-Melanoma Skin Cancer Treatment Market Share by Type (2014-2019)
Table United States Non-Melanoma Skin Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Non-Melanoma Skin Cancer Treatment Market Share by Application (2014-2019)
Figure Europe Non-Melanoma Skin Cancer Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Non-Melanoma Skin Cancer Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Non-Melanoma Skin Cancer Treatment Market Share (2018-2019)
Table Europe Non-Melanoma Skin Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Non-Melanoma Skin Cancer Treatment Market Share by Type (2014-2019)
Table Europe Non-Melanoma Skin Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Non-Melanoma Skin Cancer Treatment Market Share by Application (2014-2019)
Figure China Non-Melanoma Skin Cancer Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Non-Melanoma Skin Cancer Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Non-Melanoma Skin Cancer Treatment Market Share (2018-2019)
Table China Non-Melanoma Skin Cancer Treatment Market Size by Type (2014-20189) (Million US$)
Table China Non-Melanoma Skin Cancer Treatment Market Share by Type (2014-2019)
Table China Non-Melanoma Skin Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table China Non-Melanoma Skin Cancer Treatment Market Share by Application (2014-2019)
Figure Japan Non-Melanoma Skin Cancer Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Non-Melanoma Skin Cancer Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Non-Melanoma Skin Cancer Treatment Market Share (2018-2019)
Table Japan Non-Melanoma Skin Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Non-Melanoma Skin Cancer Treatment Market Share by Type (2014-2019)
Table Japan Non-Melanoma Skin Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Non-Melanoma Skin Cancer Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Non-Melanoma Skin Cancer Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Non-Melanoma Skin Cancer Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Non-Melanoma Skin Cancer Treatment Market Share (2018-2019)
Table Southeast Asia Non-Melanoma Skin Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Non-Melanoma Skin Cancer Treatment Market Share by Type (2014-2019)
Table Southeast Asia Non-Melanoma Skin Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Non-Melanoma Skin Cancer Treatment Market Share by Application (2014-2019)
Figure India Non-Melanoma Skin Cancer Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Non-Melanoma Skin Cancer Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Non-Melanoma Skin Cancer Treatment Market Share (2018-2019)
Table India Non-Melanoma Skin Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table India Non-Melanoma Skin Cancer Treatment Market Share by Type (2014-2019)
Table India Non-Melanoma Skin Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table India Non-Melanoma Skin Cancer Treatment Market Share by Application (2014-2019)
Figure Central & South America Non-Melanoma Skin Cancer Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Non-Melanoma Skin Cancer Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Non-Melanoma Skin Cancer Treatment Market Share (2018-2019)
Table Central & South America Non-Melanoma Skin Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Non-Melanoma Skin Cancer Treatment Market Share by Type (2014-2019)
Table Central & South America Non-Melanoma Skin Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Non-Melanoma Skin Cancer Treatment Market Share by Application (2014-2019)
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Non-Melanoma Skin Cancer Treatment Business (2014-2019) (Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Non-Melanoma Skin Cancer Treatment Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Non-Melanoma Skin Cancer Treatment Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Non-Melanoma Skin Cancer Treatment Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Non-Melanoma Skin Cancer Treatment Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Non-Melanoma Skin Cancer Treatment Business (2014-2019)
Table Eli Lilly Recent Development
Table Roche Company Details
Table Roche Revenue in Non-Melanoma Skin Cancer Treatment Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Non-Melanoma Skin Cancer Treatment Business (2014-2019)
Table Roche Recent Development
Table Merck Company Details
Table Merck Revenue in Non-Melanoma Skin Cancer Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Non-Melanoma Skin Cancer Treatment Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Non-Melanoma Skin Cancer Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Non-Melanoma Skin Cancer Treatment Business (2014-2019)
Table Novartis Recent Development
Table Mylan Company Details
Table Mylan Revenue in Non-Melanoma Skin Cancer Treatment Business (2014-2019)(Million US$)
Figure Mylan Revenue Growth Rate in Non-Melanoma Skin Cancer Treatment Business (2014-2019)
Table Mylan Recent Development
Table Sun Pharmaceutical Company Details
Table Sun Pharmaceutical Revenue in Non-Melanoma Skin Cancer Treatment Business (2014-2019)(Million US$)
Figure Sun Pharmaceutical Revenue Growth Rate in Non-Melanoma Skin Cancer Treatment Business (2014-2019)
Table Sun Pharmaceutical Recent Development
Table Almirall Company Details
Table Almirall Revenue in Non-Melanoma Skin Cancer Treatment Business (2014-2019)(Million US$)
Figure Almirall Revenue Growth Rate in Non-Melanoma Skin Cancer Treatment Business (2014-2019)
Table Almirall Recent Development
Table Elekta Company Details
Table Elekta Revenue in Non-Melanoma Skin Cancer Treatment Business (2014-2019)(Million US$)
Figure Elekta Revenue Growth Rate in Non-Melanoma Skin Cancer Treatment Business (2014-2019)
Table Elekta Recent Development
Table Varian Medical Systems Company Details
Table Sensus Healthcare Company Details
Table iCAD Company Details
Table Accuray Company Details
Table Ion Beam Applications Company Details
Table Global Non-Melanoma Skin Cancer Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Non-Melanoma Skin Cancer Treatment Market Size Share by Regions (2019-2025)
Figure Global Non-Melanoma Skin Cancer Treatment Market Size Share by Regions in 2025
Figure United States Non-Melanoma Skin Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Non-Melanoma Skin Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Non-Melanoma Skin Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Non-Melanoma Skin Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Non-Melanoma Skin Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Non-Melanoma Skin Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Non-Melanoma Skin Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Non-Melanoma Skin Cancer Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Non-Melanoma Skin Cancer Treatment Market Size by Product (2019-2025)
Figure Global Non-Melanoma Skin Cancer Treatment Market Size by Product in 2025
Table Global Non-Melanoma Skin Cancer Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Non-Melanoma Skin Cancer Treatment Market Size by Application (2019-2025)
Figure Global Non-Melanoma Skin Cancer Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の黒色腫がん市場：市場規模・現状・予測

Global Melanoma Cancer Market Size, Status and Forecast 2019-2025
QYR9N7533 2019年6月14日 96Pages
当資料は、黒色腫がんのグローバル市場について調査・分析したレポートで、種類別（非侵襲性黒色腫、浸潤性黒色腫）、用途別（病院、がん研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

...

世界の皮膚がんの診断と治療市場：市場規模・現状・予測

Global Skin Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N8050 2019年6月14日 104Pages
当資料は、皮膚がんの診断と治療のグローバル市場について調査・分析したレポートで、種類別（日光角化症（AK）、ベース細胞がん（BCC）、扁平上皮がん（SCC）、メラノーマ）、用途別（病院、がん研究センター、診療所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、...

世界の皮膚ガン市場：市場規模・現状・予測

Global Skin Cancer Market Size, Status and Forecast 2019-2025
QYR9N8049 2019年6月14日 103Pages
当資料は、皮膚ガンのグローバル市場について調査・分析したレポートで、種類別（基底細胞がん、扁平上皮がん）、用途別（病院、診療所、診断センター、がん研究所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
...

世界の炎症性皮膚疾患の治療市場：市場規模・現状・予測

Global Inflammatory Skin Diseases Treatment Market Size, Status and Forecast 2019-2025
QYR9N7365 2019年6月14日 97Pages
当資料は、炎症性皮膚疾患の治療のグローバル市場について調査・分析したレポートで、種類別（レチノイド、コルチコステロイド、カルシニューリン阻害剤、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連...

世界の黒色腫の検出市場：市場規模・現状・予測

Global Melanoma Detection Market Size, Status and Forecast 2019-2025
QYR9N7534 2019年6月14日 98Pages
当資料は、黒色腫の検出のグローバル市場について調査・分析したレポートで、種類別（生検、イメージング、その他）、用途別（病院、スキンケアクリニック、診断センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。...

世界の非血液がん治療市場：市場規模・現状・予測

Global Non-Hematological Cancer Treatment Market Size, Status and Forecast 2019-2025
QYR9N7684 2019年6月14日 94Pages
当資料は、非血液がん治療のグローバル市場について調査・分析したレポートで、種類別（化学療法、手術、放射線療法、その他）、用途別（病院、腫瘍治療センター、外来手術センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれ...

世界の転移性乳がんの治療市場：市場規模・現状・予測

Global Metastatic Breast Cancer Treatment Market Size, Status and Forecast 2019-2025
QYR9N7553 2019年6月14日 96Pages
当資料は、転移性乳がんの治療のグローバル市場について調査・分析したレポートで、種類別（化学療法、放射線療法、生物学的標的療法、乳房手術、ホルモン療法）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含...

世界の口腔がんの治療市場：市場規模・現状・予測

Global Oral Cancer Treatment Market Size, Status and Forecast 2019-2025
QYR9N7715 2019年6月14日 98Pages
当資料は、口腔がんの治療のグローバル市場について調査・分析したレポートで、種類別（扁平上皮がん、疣状がん、小唾液腺がん、リンパ腫）、用途別（病院と診療所、研究機関、学術機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...

世界の転移性大腸がんの治療市場：市場規模・現状・予測

Global Metastatic Colorectal Cancer Treatment Market Size, Status and Forecast 2019-2025
QYR9N7555 2019年6月14日 95Pages
当資料は、転移性大腸がんの治療のグローバル市場について調査・分析したレポートで、種類別（手術、化学療法）、用途別（病院、診療所、がん研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の黒色腫市場：市場規模・現状・予測

Global Melanoma Market Size, Status and Forecast 2019-2025
QYR9N7532 2019年6月14日 97Pages
当資料は、黒色腫のグローバル市場について調査・分析したレポートで、種類別（表在性黒色腫、結節性黒色腫、悪性ほくろメラノーマ、先天性）、用途別（病院、製薬会社、研究センター、診療所、実験室）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...

世界の黒色腫がん市場：市場規模・現状・予測 Melanoma Cancer is a skin cancer that develops due to expose of UV rays on the skin.Increasing incidence of melanoma across the globe and rising ozone layer depletion due to global warming are the major factors that are driving the market during the forecast period. Additionally, overexposure to rad…
世界の転移性乳がんの治療市場：市場規模・現状・予測 Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
世界の皮膚がんの診断と治療市場：市場規模・現状・予測 Skin cancer is the uncontrolled development of anomalous skin cells.The major factor that drives the market is that when the sun rays that is the ultra violet rays comes in contact with skin may cause skin cancer. In 2018, the global Skin Cancer Diagnosis and Therapeutics market size was xx million …
世界の非血液がん治療市場：市場規模・現状・予測 Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient.North America has the huge number of population suffering fro…
世界の光線力学療法市場：市場規模・現状・予測 In 2018, the global Photodynamic Therapy market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Photodynamic Therapy status, future forecast, growth opportunity, key market and key players. The study …